Plain Language Summary: 5-Year Results from the CROWN Study of Lorlatinib Vs Crizotinib in Non-Small-cell Lung Cancer
FUTURE ONCOLOGY(2024)
Key words
5-year results,ALK inhibitor,clinical trial,crizotinib,CROWN,lorlatinib,non-small cell lung cancer,plain language summary
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined